AQR Capital Management - PROTEOSTASIS THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 87 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
AQR Capital Management ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$22,000–17,642–0.00%–
 Download
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q1 2019.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders